Friday, 13 Dec 2019

RA/Inflammatory arthritis

Date Typesort ascending Title Save
20 Jul 2017 Social RA ACPA+ have higher economic burden w/ MORE early DMARD(71 vs 50%) & Biologics (20 vs 12%); MD visits; Total cost$ https://t.co/le0vgHKaPL
12 Oct 2017 Social prospective 16wk study of NSAID W/D in RA w/ DAS<3.2-85% success w/o change in DAS28 or PRO, esp in those w/ SJC=0 https://t.co/OVeEyeMS5G
07 Nov 2017 Social RT @WShergy: Does communication with your patients through an office electronic portal allow for better RA outcomes. acr2017 @rheumnow#2032
10 Feb 2018 Social Dr Mark Genovese #RWCS - but only 10-30% DAS revision when used in RA patients who failed a TNF inhibitor https://t.co/8aJl6kz9H1
04 May 2018 Social RT @ImmunologyNews: Effect of tear supplements on signs, symptoms and inflammatory markers in dry eye #OA https://t.co/Hgvjv0PBhE https://t…
25 Jun 2018 Social Taiwan claims analysis of #RA patients shows that despite low rates (10-20%) of influenza vaccination, those vaccinated had a significant ~35% lower rate of death and hospitalization (sepsis, bacteremia, viremia) https://t.co/Y17d66AZnC
20 Sep 2018 Social Chronic back pain suspected of having axial spondyloarthritis (axSpA) should not undergo follow-up MRI of the sacroiliac joint (MRI-SI) within a year if they had a previously negative baseline MRI-SI https://t.co/OoXDzcBTNd
06 Dec 2018 Social J. Hopkins study of 27 pts with inflammatory arthritis due to immune checkpoint inhibitors (mostly European ancestry) shows higher rate (61.5%) of at least 1 Shared Epitope allele (similar to RA pts) but were more likely to be seronegative for RF or CCP https://t.co/uR7ESZ2s07
07 Mar 2019 Social Rule of thumb on VTE risks: Normal population 0-.4/100PYs; RA patients are increased at 0.3-0.7/100 PY. If a new RA drug were to cause VTE (venous thromboembolic events; DVT/PE) it would have to have a rate consistently higher than 0.5 and probably higher than 0.7/100PY
17 Jun 2019 Social RT @sclerodermaUM: Vagal nerve stimulation for management of RA. Effective in refractory RA #EULAR2019 https://t.co/petEUKty7v
21 Aug 2019 Social Analysis of 128 Pediatric Rheum pts (JIA, FMF, etc) analzyed for reactions to 8 different biologics during 32,494 infusions/injections - the frequency of anaphylaxis (from TCZ or RTX) was 3.9% in children. https://t.co/GzvcR0R7Bv
01 Nov 2019 Social Canadian analysis of 1,183 newly diagnosed JIA - the incidence of uveitis was 2.8% per year. In multivariable analysis, the only independent risk factors were age <7 years at JIA diagnosis (HR 8.3) and +ANA (HR 3.2). https://t.co/IHgwcpmEJi
02 Dec 2019 Social ESPOIR cohort with 172 early seronegative #RA patients finds that early csDMARD use (within 3 mos of Sx) was more likely to predict better outcomes that other prognostic risk (clinical lab or imaging) factors https://t.co/76J93mZ2NH
24 Sep 2015 Social Advances in translational rheum research; from bench 2 bedside. Nature Rev Rheumatology http://t.co/Voi8Thek9J
31 Aug 2016 Social #RA, In the Last 10 yrs in Ireland, hosp & surgery cut half, MTX use tripled & TNFi up 4900% https://t.co/KUVhvqxgsc https://t.co/lc46pEHKZ5
25 Jun 2015 Social RT @DrPetryna: @RheumNow SHARE makes management of auto inflammatory diseases easier - http://t.co/ENuZImXgFz
16 Nov 2016 Social RT @rachelthuston: Premature mortality risk in gout unchanged compared to reduced premature mortality in RA pts. #ACR16 @RheumNow https://t…
29 Apr 2017 Social RT @DrRachelTate: 50% of ATTR pts (most common familial amyloid form) present with CTS years prior to onset cardiomyopathy. C. Libbey, MD @…
20 Aug 2017 Social RT @philipcrobinson: Use for 2-3 weeks for relief. AB Rx for small bowel overgrowth in scleroderma #SSR17 https://t.co/TYWiCu18oT
04 Nov 2017 Social RT @KDAO2011: Dr L Gensler #ACR17: EDS and JHS can mimic inflammatory arthritis and spondyloarthritis @Rheumnow